BSD Medical Corporation Announces Investor & Analyst Conference Call

  BSD Medical Corporation Announces Investor & Analyst Conference Call

Live Conference Call and Webcast Scheduled for Thursday, July 10 at 2:00 p.m.
             Eastern Time/12:00 p.m. Mountain Time; RSVP Required

Business Wire

SALT LAKE CITY -- June 30, 2014

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of
medical systems that utilize heat therapy to treat cancer, today announced
that it will host an Investor & Analyst Update Call and live webcast on
Thursday, July 10, 20114 at 2:00 p.m. Eastern time/12:00 p.m. Mountain time.
The call will be hosted by Harold Wolcott, President and William Barth, CFO.

Individuals interested in participating in the conference call may do so by
visiting the Investor Relations section of the Company's website at or by dialing 800.860.2442 from the United States, or
412.858.4600 from outside the United States, and referencing “BSD Medical.” We
request that you RSVP to the conference call by emailing
before 4:00 p.m. Eastern time on Tuesday, July 8, 2014.

A telephone replay will be available through July 18, 2014, by dialing
877.344.7529 from the United States, or 412.317.0088 from outside the United
States, and entering conference ID 10048867. A webcast replay will be
available for 90 days.

About BSD Medical Corporation

BSD Medical Corporation develops, manufactures, markets and services systems
to treat cancer and benign diseases using heat therapy, which is delivered
using focused radiofrequency (RF) and microwave energy. BSD’s product lines
include both hyperthermia and ablation treatment systems. BSD’s MicroThermX^®
microwave ablation system has been developed as a stand-alone therapy to
employ precision-guided microwave energy to ablate (destroy) soft tissue. The
Company has developed extensive intellectual property, multiple products in
the market and established distribution in the United States, Europe and Asia.
Certain of the Company’s products have received regulatory approvals and
clearances in the United States, Europe and China.

For further information visit BSD Medical's website at

Forward-Looking Statements

Statements contained in this press release that are not historical facts,
including statements relating to our 2014 plans, are forward-looking
statements, as defined in the Private Securities Litigation Reform Act of
1995. All forward-looking statements are subject to risks and uncertainties
detailed in the Company's filings with the Securities and Exchange Commission,
including the market demand for our MicroThermXproducts and the regulatory
requirements we face. These forward-looking statements speak only as of the
date on which such statements are made, and the Company undertakes no
obligation to update such statements to reflect events or circumstances
arising after such date, except as required by law.


Financial Profiles
Tricia Ross, 310-622-8226
Press spacebar to pause and continue. Press esc to stop.